01 1Harman Finochem
01 1LINAGLIPTIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-12-20
Pay. Date : 2023-09-25
DMF Number : 38819
Submission : 2023-09-27
Status : Active
Type : II
20
Harman Finochem Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LINAGLIPTIN, with a corresponding US DMF Number 38819.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 20, 2023, and payment made on September 25, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
